Literature DB >> 15015849

[Recurrence after surgical treatment of Buruli ulcer in Cote d'Ivoire].

J M Kanga1, D E Kacou, A Sangaré, Y Dabila, N H Asse, S Djakeaux.   

Abstract

Current treatment of Buruli ulcer is mainly surgical. However, surgical management is difficult due to occurrence of more and more recurrent cases after treatment. This cross section study has been carried out from records of 346 Buruli ulcer patients who have received surgical treatment in three health centers in Cote d'Ivoire. Its purposes consisted in assessing the recurrence rate, in describing its aspects and in identifying its causes. Results showed that recurrent cases during Buruli ulcer were relatively frequent after surgery with a rate of 17.1%. They occurred early during hospitalization in an average of 5 months after surgery. They appeared mostly in ulceration form and were located on the previous lesion site. After statistical analysis, the following risk factors are associated with Buruli ulcer recurrent cases: patient under 30 years old, previous contact with a watercourse, duration of the disease exceeding 75 days before hospitalization, secondary infection before or after surgery disability, treatment by excision and skin graft, ongoing healing of operated wound. Recurrent cases after surgical treatment should not be neglected during Mycobacterium ulcerans infection. Surgeon must consider their prevention during patients treatment.

Entities:  

Mesh:

Year:  2003        PMID: 15015849

Source DB:  PubMed          Journal:  Bull Soc Pathol Exot        ISSN: 0037-9085


  7 in total

1.  Secondary Buruli ulcer skin lesions emerging several months after completion of chemotherapy: paradoxical reaction or evidence for immune protection?

Authors:  Marie-Thérèse Ruf; Annick Chauty; Ambroise Adeye; Marie-Françoise Ardant; Hugues Koussemou; Roch Christian Johnson; Gerd Pluschke
Journal:  PLoS Negl Trop Dis       Date:  2011-08-02

2.  The contribution of community health workers to the control of Buruli ulcer in the Ngoantet area, Cameroon.

Authors:  Marius Zambou Vouking; Innocent Takougang; Léonard Mbam Mbam; Lawrence Mbuagbaw; Carine Nouboudem Tadenfok; Claire Violette Tamo
Journal:  Pan Afr Med J       Date:  2013-10-22

3.  Mycobacterium ulcerans Disease with Unusual Sites Not to Be Ignored.

Authors:  Sangaré Abdoulaye; Kourouma Sarah Hamdan; Kouassi Yao Isidore; Ecra Elidjé Joseph; Kaloga Mamadou; Gbery Ildevert Patrice
Journal:  Dermatol Res Pract       Date:  2014-10-16

Review 4.  Buruli Ulcer: a Review of the Current Knowledge.

Authors:  Rie R Yotsu; Koichi Suzuki; Rachel E Simmonds; Roger Bedimo; Anthony Ablordey; Dorothy Yeboah-Manu; Richard Phillips; Kingsley Asiedu
Journal:  Curr Trop Med Rep       Date:  2018-09-28

Review 5.  Drugs for treating Buruli ulcer (Mycobacterium ulcerans disease).

Authors:  Rie R Yotsu; Marty Richardson; Norihisa Ishii
Journal:  Cochrane Database Syst Rev       Date:  2018-08-23

6.  A Genomic Approach to Resolving Relapse versus Reinfection among Four Cases of Buruli Ulcer.

Authors:  Miriam Eddyani; Koen Vandelannoote; Conor J Meehan; Sabin Bhuju; Jessica L Porter; Julia Aguiar; Torsten Seemann; Michael Jarek; Mahavir Singh; Françoise Portaels; Timothy P Stinear; Bouke C de Jong
Journal:  PLoS Negl Trop Dis       Date:  2015-11-30

7.  Socio-Environmental Factors Associated with the Risk of Contracting Buruli Ulcer in Tiassalé, South Côte d'Ivoire: A Case-Control Study.

Authors:  Raymond T A S N'krumah; Brama Koné; Issaka Tiembre; Guéladio Cissé; Gerd Pluschke; Marcel Tanner; Jürg Utzinger
Journal:  PLoS Negl Trop Dis       Date:  2016-01-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.